B. Metzler seel. Sohn & Co’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Buy
26,361
+9,108
+53% +$1.12M 0.03% 296
2026
Q1
$2.03M Buy
17,253
+9,280
+116% +$1.3M 0.02% 379
2025
Q4
$1.31M Hold
7,973
0.01% 497
2025
Q3
$1.07M Hold
7,973
0.01% 528
2025
Q2
$992K Hold
7,973
0.01% 543
2025
Q1
$1.01M Hold
7,973
0.01% 518
2024
Q4
$1.15M Hold
7,973
0.01% 504
2024
Q3
$1.19M Sell
7,973
-2,956
-27% -$424K 0.01% 513
2024
Q2
$1.38M Buy
10,929
+61
+0.6% +$9.56K 0.01% 456
2024
Q1
$2M Sell
10,868
-497
-4% -$94.6K 0.02% 383
2023
Q4
$2.04M Buy
11,365
+874
+8% +$136K 0.03% 363
2023
Q3
$1.67M Sell
10,491
-3,801
-27% -$621K 0.03% 353
2023
Q2
$2.02M Buy
14,292
+7,102
+99% +$1.14M 0.03% 374
2023
Q1
$1.21M Buy
7,190
+539
+8% +$96.2K 0.02% 406
2022
Q4
$1.13M Buy
6,651
+998
+18% +$181K 0.02% 405
2022
Q3
$1.06M Buy
5,653
+141
+3% +$29.7K 0.02% 410
2022
Q2
$895K Hold
5,512
0.01% 462
2022
Q1
$1.04M Buy
+5,512
New +$1.05M 0.01% 468

Other funds holding RGEN

B. Metzler seel. Sohn & Co's RGEN Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Repligen (RGEN) stake by 53% in Q2 2026, buying an estimated $1.12M and bringing the position to 26,361 shares worth $3.6M. The position accounts for 0.03% of the portfolio, ranked #296.

B. Metzler seel. Sohn & Co first reported a position in RGEN in Q1 2022 and has held it in 18 quarters since. 253 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 26,361 shares of Repligen worth $3.6M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 9,108 Repligen shares in Q2 2026, an estimated $1.12M.
  • Repligen made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #296 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Repligen in Q1 2022 and has held it in 18 quarters since.
  • 253 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.